Spain: Big Ticket Infrastructural Investments
Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing,…
EUROPE
Government Sector Organisations: France
The healthcare and life sciences industries, as they become more advanced and complex, increasingly require…
Hungary Biotech Cluster Map
Hungary’s medicinal biotech companies are clustered in the country’s four major university towns:…
Austria: Nucleus of Clinical Trials
Like a family recipe that has been refined and perfected over countless generations, Austria has developed a…
GSK and Pfizer Consumer Health Divisions to Merge
The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint…
The European Medicines Verification System Launches to Tackle Fake Drugs
The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use…
A Pivot Towards Recruitment Process Outsourcing (RPO) in the Baltics
As the Lithuanian market matures, profound shifts have been taking place in the arena of human resources and how…
Biotech in Spain: Top Facts
This map of the distribution of biotech companies throughout Spain shows that the country’s most…
Hungary Facts & Figures Snapshot
The following chart shows the top pharma companies in Hungary ranked by sales value. Global giant Novartis leads…
In Conversation
Interview: Philip Hendrick – Managing Director, Air Liquide Healthcare Ireland
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they are at the forefront of transitioning the healthcare system from hospital based to home-based Philip, as an introduction for our international readers, could you provide us with an overview of…
People To Know
Andrea Recordati
CEO | Recordati
Deborah Dunsire
CEO, President | Lundbeck
Alexandre Mérieux
Chairman, CEO | bioMérieux
Brenton Saunders
CEO, Chairman | Allergan
Jakob Lindberg
CEO | Oncopeptides
Lars Fruergaard Jørgensen
Executive Vice President, CEO | Novo Nordisk
Gábor Orbán
CEO | Gedeon Richter
Valerie Poinsot
Deputy CEO | Boiron
Raimund Bruhin
Executive Director | Swissmedic
Francesco De Santis
President | Italfarmaco
Latest Reports
Focus on France
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from…
Servier’s Olivier Laureau: Change Instigator
Not long ago, Laboratories Servier was considered a somewhat mysterious and…
Read more from France >>
Focus on Sweden
How Big Pharma Leverages Sweden’s Booming Digital…
Sweden is considered a world leader in technology, and its innovative electronic…
Stockholm: A Hidden Jewel of Life Sciences Innovation in…
Some of the key stakeholders in Swedish healthcare and life sciences outline why…
Read more from Sweden >>
Focus on Switzerland
Swiss Mid-Caps and Minnows: At the Vanguard of Creativity
In view of the manifold hurdles encountered when attempting to raise capital,…
Roche Fights off Biosimilar Competition to Grow 7% in 2018
Roche announced strong Group sales growth of seven percent for 2018, partly…
Read more from Switzerland >>
Focus on Spain
Esteve: Out with the Old; In with the New
Esteve has long been a family-run business, though in early 2018 the Spanish…
Spanish Mid-Caps: Going Global
Despite the Spanish economy and pharmaceutical market’s steady growth, many…
Read more from Spain >>
Legal Q&As
Preclinical and Clinical Trial Requirements: Portugal
Preclinical and clinical trials in Portugal – a legal guide. Prepared in association with Cuatrecasas, a…
Patents & Trademarks: Croatia
Patents and trademarks in Croatia – a comprehensive legal overview. Prepared in association with Danijel…
Regulatory, Pricing and Reimbursement: Croatia
An intro to the legal situation for regulatory, pricing and reimbursement of drugs in Croatia. Prepared in…
Diabetes in Lithuania: A Silent Crisis
With over 120,000 people whose lives are affected by the disease in Lithuania; diabetes stands as one of the…
Nationalism & Populism: A Roadblock for Global Pharma
Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom,…
Austria: Orchestrating Innovation
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research…
Thomas Cueni on pricing and developing markets
In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical…
Portugal’s Potential as a Pharma Testing Ground
Portugal has forged a name for itself in terms of early adoption of new technology and ideas; making the country a…
Natural Products and Supplements in Serbia: A Growth Spot
In a market environment that, up until recently, has been severely difficult for producers of chemical…